Contraceptive vaccines

Bibliography

• BAIRD DT, GLASIER AF: Science, medicine, and the future. Contraception. Br. Med. J. (1999) 319:969–972.
   PubMed Web of Science ®Google Scholar
• GUPTA SK: The immunology of reproduction: update. Immunol Today (1998) 19:433–434.
   PubMedGoogle Scholar
• ALEXANDER NJ, BIALY G: Contraceptive vaccine development. Reprod. Fertil. Dev. (1994) 6:273–280.
   PubMed Web of Science ®Google Scholar
• BEDFORD JM: Sperm/egg interaction: the specificity of human spermatozoa. Anat. Rec (1977) 188:477–488.
   PubMedGoogle Scholar
• SZCZEPANSKA M, SKRZYPCZAK J, KAMIENICZNA M, KURPISZ M: Antizona and antisperm antibodies in women with endometriosis and/or infertility. Fertil. Stern. (2001) 75:97–105
   PubMed Web of Science ®Google Scholar
• HOVAV Y, ALMAGOR M,BENBENISHTI D, MARGALIOTH EJ, KAFKA I, YAFFE H: Immunity to zona pellucida in women with low response to ovarian stimulation, in unexplained infertility and after multiple IVF attempts. Hum. Reprod. (1994) 9:643–645.
   PubMed Web of Science ®Google Scholar
• WASSARMAN PM: Zona pellucida glycoproteins. Ann. Rev Biochem. (1988) 57:415–442.
   PubMed Web of Science ®Google Scholar
• RANKIN T, FAMILARI M, LEE E et al: Mice homozygous for an insertional mutation in the Zp3 gene lack a zona pellucida and are infertile. Development (1996) 122:2903–2910.
   PubMed Web of Science ®Google Scholar
• RANKIN T, TALBOT P, LEE E, DEAN J: Abnormal zonae pellucidae in mice lacking ZP1 result in early embryonic loss. Development (1999) 126:3847–3855.
   PubMed Web of Science ®Google Scholar
• RANKIN TL, O& BRIEN M, LEE E, WIGGLESWORTH K, EPPIG J, DEAN J: Defective zonae pellucidae in Zp2-null mice disrupt folliculogenesis, fertility and development. Development (2001) 128:1119–11126.
   PubMed Web of Science ®Google Scholar
• PRASAD SV, WILKINS B, SKINNER SM,DUNBAR BS: Evaluating zona pellucida structure and function using antibodies to rabbit 55 kDa ZP protein expressed in baculovirus expression system. Ma Reprod. Dev (1996) 43:519–529.
   PubMed Web of Science ®Google Scholar
• GOVIND CK, GAHLAY GK,CHOUDHURY S, GUPTA SK: Purified and refolded recombinant bonnet monkey (Maraca radiata) zona pellucida glycoprotein-B expressed in Escherichia coilbinds to spermatozoa. Biol. Reprod. (2001) 64:1147–1152.
   PubMed Web of Science ®Google Scholar
• KIRKPATRICK JF, TURNER JW JR, LIU IK, FAYRER-HOSKEN R: Applications of pig zona pellucida immunocontraception to wildlife fertility control. Reprod. Fertil. Stipp]. (1996) 50:183–189.
   PubMedGoogle Scholar
• PATERSON M, WILSON MR, MORRIS KD, VAN DUIN M, AITKEN RJ: Evaluation of the contraceptive potential of recombinant ZP3 and human ZP3 peptides in a primate model - their safety and efficacy. Am. J. Reprod. Immunol (1998) 40:198–209.
   PubMed Web of Science ®Google Scholar
• HENDERSON CJ, BRAUDE P,AITKEN RJ: Polyclonal antibodies to a 32 kDa deglycosylated polypeptide from the porcine zona pellucida will prevent human gamete interaction M vitro. Gamete Res. (1987) 18:251–265.
   PubMedGoogle Scholar
• HENDERSON CJ, HULME MJ, AITKEN RJ: Analysis of the biological properties of antibodies raised against intact and deglycosylated porcine zonae pellucidae. Gamete Res. (1987) 16:323–341.
   PubMedGoogle Scholar
• TURNER JW JR, LIU IK,FLANAGAN DR, BYNUM KS, RUTBERG AT: Porcine zona pellucida (PZP) immunocontraception of wild horses (Equus caballus) in Nevada: a 10 year study. Reproduction (2002) 60(Suppl.):177–186.
   Google Scholar
• •Recent example of contraceptive vaccines targeting the ZP finding application in the control of feral animal populations.
   Google Scholar
• JACKSON RJ, MAGUIRE DJ,HINDS LA, RAMSHAW IA: Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol. Reprod. (1998) 58:152–159.
   PubMed Web of Science ®Google Scholar
• AITKEN RJ, PATERSON M,VAN DUIN M: The potential of the zona pellucida as a target for immunocontraception. Am. J. Reprod. Immunol (1996) 35:175–180.
   PubMed Web of Science ®Google Scholar
• AITKEN RJ: Immunocontraceptive vaccines for human use." Reprod. I,nmunol. (2002) 57:273–287.
   Google Scholar
• ••Recent review of the status of contraceptivevaccines targeting the ZP, sperm surface and implanting embryo.
   Google Scholar
• KERR PJ, JACKSON RJ, ROBINSON AJ et al.: Infertility in female rabbits (Oryctolagus cuniculus) alloimmunized with the rabbit zona pellucida protein ZPB either as a purified recombinant protein or expressed by recombinant myxoma virus. Biol. Reprod. (1999) 61:606–613.
   Google Scholar
• JONES GR, SACCO AG,SUBRAMANIAN MG et al.: Histology of ovaries of female rabbits immunized with deglycosylated zona pellucida macromolecules of pigs. J. Reprod. Feral. (1992) 95:513–525.
   Google Scholar
• PATERSON M, KOOTHAN PT, MORRIS KD et al.: Analysis of the contraceptive potential of antibodies against native and deglycosylated porcine ZP3 in vivo and M vitro. Biol. Reprod. (1992) 46:523–534.
   PubMed Web of Science ®Google Scholar
• •This paper clearly demonstrates that the ovarian pathology associated with the induction of active immunity against ZP antigens is not dependent on glycosylation, but is triggered by antibodies directed against the peptide core of these molecules.
   Google Scholar
• GARZA KM, TUNG KS: Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction.' Immunol (1995) 155:5444–5448.
   Web of Science ®Google Scholar
• LOU Y, ANG J, THAI H, MCELVEEN F,TUNG KS: A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology. J.Immunol. (1995) 155:2715–27120.
   PubMed Web of Science ®Google Scholar
• PATERSON M, JENNINGS Z, WILSON MR, AITKEN RJ: The contraceptive potential of ZP3 and ZP3 peptides in a primate model." Reprod. Immunol (2002) 53:99–107.
   PubMed Web of Science ®Google Scholar
• BAGAVANT H, FUSI FM, BAISCH J, KURTH B, DAVID CS, TUNG KS: Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine. Biol. Reprod. (1997) 56:764–770.
   PubMed Web of Science ®Google Scholar
• HULL MGR, GLAZENER CMA, KELLY NJ et al.: Population study of causes, treatment and outcome of infertility. Br. Med. J. (1985) 291:1693–1697.
   PubMed Web of Science ®Google Scholar
• BASKIN MJ: Temporary sterilization by the injection of human spermatozoa. A preliminary report. Am. .1. Obst. Gyn. (1932) 24:892–897.
   Google Scholar
• •Historically important paperdemonstrating that human semen containsantigens with contraceptive potential.
   Google Scholar
• AITKEN RJ, PARSLOW JM, HARGREAVE TB, HENDRY WF: Influence of antisperm antibodies on human sperm function. Br. J. Um]. (1988) 62:367–373.
   PubMed Web of Science ®Google Scholar
• GUPTA I, DHAWAN S, GOEL GD, SAHA K: Low fertility rate in vasovasostomized males and its possible immunologic mechanism. Int. I Fertil. (1975) 20:183–191.
   PubMedGoogle Scholar
• O'RAND MG: Inhibition of fertility and sperm-zona binding by antiserum to the rabbit sperm membrane autoantigen RSA-1. Biol. Reprod (1981) 25:621–628.
   Google Scholar
• PRIMAKOFF P, LATHROP W,WOOLMAN L, COWAN A, MYLES DG: Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature (1988) 35:543–546.
   Google Scholar
• PRIMAKOFF P, HYATT H,TREDICK-KLINE J: Identification and purification of a sperm surface protein with a potential role in sperm-egg membrane fusion.j Cell Biol. (1987) 104:141–149.
   PubMed Web of Science ®Google Scholar
• KUAMAYA PTP, VAN BUSKIRK AM, GOLDBERG E, PIERCE SK: Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines. J. Biol. Chem. (1992) 267:6338–6346.
   PubMed Web of Science ®Google Scholar
• HERR JC, FLICKINGER CJ, HOMYK M, KLOTZ K, JOHN E: Biochemical and morphological characterisation of the intra-acrosomalantigen SP-10 from human sperm. Biol. Reprod. (1990) 42:181–193.
   PubMed Web of Science ®Google Scholar
• BLEIL JD, WASSARMAN PM: Identification of a ZP3-binding protein on acrosome-intact mouse sperm by photoaffinity crosslinking. Proc. Natl. Acad. Sci. USA (1990) 87:5563–5567.
   PubMed Web of Science ®Google Scholar
• NAZ RK, WOLF DP: Antibodies to sperm-specific human FA-1 inhibit M vitro fertilization in rhesus monkeys: development of a simian model for testing of anti-FA- 1 contraceptive vaccine. Reprod. Immunol (1994) 27:111–121.
   PubMed Web of Science ®Google Scholar
• LEFEVRE A, MARTIN RUIZ C, CHOKOMIAN S, DUQUENNE C, FINAZ C: Characterization and isolation of 50B2, a human sperm protein with a potential role in oocyte membrane binding. MM. Hum. Reprod. (1997) 3:507–516.
   PubMed Web of Science ®Google Scholar
• DIEKMAN AB, NORTON EJ,KLOTZ KL, WESTBROOK VA,HERR JC: Evidence for a unique N-linked glycan associated with human infertility on sperm CD52: a candidate contraceptive vaccinogen. Immunol Rev. (1999) 171:203–211.
   PubMed Web of Science ®Google Scholar
• BABA D, KASHIWABARA S, HONDA A et al.: Mouse sperm lacking cell surface hyaluronidase PH-20 can pass through the layer of cumulus cells and fertilize the egg. Bia Chem. (2002) 277:30310–30314.
   PubMed Web of Science ®Google Scholar
• •Important paper indicating that PH20 is not essential for fertilisation and, therefore, not a candidate for contraceptivevaccine development.
   Google Scholar
• TUNG KS, PRIMAKOFF P,WOOLMAN-GAMER L, MYLES DG: Mechanism of infertility in male guinea pigs immunized with sperm PH-20. Biol. Reprod. (1997) 56:1133–1141.
   PubMed Web of Science ®Google Scholar
• HOLLAND MK, ANDREWS J, CLARKE H, WALTON C, HINDS LA: Selection of antigens for use in a virus-vectored immunocontraceptive vaccine: PH-20 as a case study. Reprod. Feral. Dev. (1997) 9:117–124.
   PubMed Web of Science ®Google Scholar
• POMERING M, JONES RC,HOLLAND MK, BLAKE AE,BEAGLEY KWP: Restricted entry of IgG into male and female rabbit reproductive ducts following immunization with recombinant rabbit PH-20. Am. Reprod. Immunol (2002) 47:174–182.
   PubMed Web of Science ®Google Scholar
• DENG X, HEY, MARTIN-DELEON PA: Mouse Spaml (PH-20): evidence for its expression in the epididymis and for a new category of spermatogenic-expressed genes. J. Andra (2000) 21:822–832.
   PubMed Web of Science ®Google Scholar
• ZHANG H, MARTIN-DELEON PA: Mouse Epididymal Spaml (PH-20) is released in the luminal fluid with its lipid anchor. Andra (2003) 24:51–58.
   PubMed Web of Science ®Google Scholar
• ZHANG H, MARTIN-DELEON PA: Mouse Spaml (PH-20) is a multifunctional protein: Evidence for its expression in the Female reproductive tract. Biol. Reprod. (2003) (e-Pub ahead of print).
   Google Scholar
• O'HERN PA, BAMBRA CS,ISAHAKIA M, GOLDBERG E: Reversible contraception in female baboons immunized with a synthetic epitope of sperm-specific lactate dehydrogenase. Biol. Reprod. (1995) 52:331–339.
   PubMed Web of Science ®Google Scholar
• O'HERN PA, LIANG ZG, BAMBRA CS, GOLDBERG E: Colinear synthesis of an antigen-specific B-cell epitope with a 'promiscuous' tetanus toxin T-cell epitope: a synthetic peptide immunocontraceptive. Vaccine (1997) 15:1761–1766.
   PubMed Web of Science ®Google Scholar
• GUPTA GS, MALHOTRA R:Autoimmune-like activity of sperm specific LDH: a pathophysiological and electron microscopic study of atrophied testis and epididymis. Indianj Biochem. Biophys. (1994) 31:480–485.
   PubMed Web of Science ®Google Scholar
• GOLDBERG E, VANDEBERG JL, MAHONY MC, DONCEL GF: Immune response of male baboons to testis-specific LDH-C(4). Contraception (2001) 64:93–98.
   PubMed Web of Science ®Google Scholar
• HERR J: Update on sperm antigen-based contraceptive vaccines. Immunol Allergy Clin. North Am. (2002) 22:503–527.
   Web of Science ®Google Scholar
• CHENG A, LET, PALACIOS M et al: Sperm-egg recognition in the mouse: characterization of sp56, a sperm protein having specific affinity for ZP3. J. Cell Biol. (1994) 125:867–878.
   PubMed Web of Science ®Google Scholar
• HARDY CM, MOBBS KJ: Expression of recombinant mouse sperm protein sp56 and assessment of its potential for use as an antigen in an immunocontraceptive vaccine. Ma Reprod. Dev. (1999) 52:216–224.
   PubMed Web of Science ®Google Scholar
• KIM KS, CHA MC, GERTON GL: Mouse sperm protein sp56 is a component of the acrosomal matrix. Biol. Reprod (2001) 64:36–43.
   PubMed Web of Science ®Google Scholar
• COHEN N,WASSARMAN PM: Association of egg zona pellucida glycoprotein mZP3 with sperm protein sp56 during fertilization in mice. Int. Dev. Biol. (2001) 45:569–576.
   PubMed Web of Science ®Google Scholar
• BLOBEL CP, WOLFSBERG TG, TURCK CW, MYLES DG,PRIMAKOFF P, WHITE JM: A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature (1992) 356:248–252.
   PubMed Web of Science ®Google Scholar
• WOLFSBERG TG, STRAIGHT PD, GERENA RL et al.: ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. (1995) 169:378–383.
   PubMed Web of Science ®Google Scholar
• FRAYNE J, JURY JA, BARKER HL, HALL L: Rat MDC family of proteins: sequence analysis, tissue distribution, and expression in prepubertal and adult rat testis. Ma Reprod. Dev (1997) 48:159–167.
   PubMed Web of Science ®Google Scholar
• MYLES DG, KIMMEL LH, BLOBEL EP, WHITE JM, PRIMAKOFF P: Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc. Nati Acad. Sci. USA (1994) 91:4195–4198.
   PubMed Web of Science ®Google Scholar
• EVANS JP, SCHULTZ RM, KOPF GS: Roles of the disintegrin domains of mouse fertilins alpha and beta in fertilization. Biol. Reprod. (1998) 59:145–152.
   PubMed Web of Science ®Google Scholar
• RAMARAO CS, MYLES DG, WHITE JM, PRIMAKOFF P: Initial evaluation of fertilin as an immunocontraceptive antigen and molecular cloning of the cynomolgus monkey fertilin beta subunit. Ma Reprod. Dev (1996) 43:70–75.
   PubMed Web of Science ®Google Scholar
• HARDY CM, CLARKE HG, NIXON B, GRIGG JA, HINDS LA, HOLLAND MK: Examination of the immunocontraceptive potential of recombinant rabbit fertilin subunits in rabbit. Biol. Reprod. (1997) 57:879–886.
   PubMed Web of Science ®Google Scholar
• HE ZY, BRAKEBUSCH C, FASSLER R, KREIDBERG JA, PRIMAKOFF P, MYLES DG: None of the integrins known to be present on the mouse egg or to be ADAM receptors are essential for sperm-egg binding and fusion. Dev. Biol. (2003) 254:226–237.
   PubMed Web of Science ®Google Scholar
• ••Recent demonstration that neitherintegrins on the surface of the oocyte, nor presumably the sperm ADAM proteins that target them, are involved in sperm-oocyte fusion. These molecules, therefore, are unlikely to be effective targets for contraceptive vaccines.
   Google Scholar
• MCLAUGHLIN EA, FRAYNE J, BLOOMERG G, HALL L: Do fertilin beta and cyritestin play a major role in mammalian sperm-oolemma interactions? A critical re-evaluation of the use of peptide mimics in identifying specific oocyterecognition proteins. Ma Hum. Reprod (2001) 7:313–317.
   PubMed Web of Science ®Google Scholar
• JURY JA, FRAYNE J, HALL L: The humanfertilin alpha gene is non-functional: implications for its proposed role in fertilization. Biochem.f. (1997) 321:577–581.
   PubMed Web of Science ®Google Scholar
• TALWAR GP: Fertility regulating andimmunotherapeutic vaccines reaching human trials stage. Hum. Reprod. Update (1997) 3:301–310.
   PubMed Web of Science ®Google Scholar
• •Review of the status of contraceptive vaccines targeting hCG.
   Google Scholar
• SINGH M, DAS SK, SURI S, SINGH O, TALWAR GP: Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine. Am. Reprod. Immunol (1998) 39:395–398.
   PubMed Web of Science ®Google Scholar
• MANDOKHOT A, PAL R, NAGPAL S, CHAUHAN VS, AHLAWAT S,SINGH O: Humoral hyporesponsiveness to a conjugate contraceptive vaccine and its bypass by diverse carriers using permissible adjuvant. Gin. Exp. Immunol. (2000) 122:101–108.
   PubMed Web of Science ®Google Scholar
• MUKHOPADHYAY A: Reversible protection of disulfide bonds followed by oxidative folding render recombinant hCG beta highly immunogenic. Vaccine (2000) 18:1802–1810.
   PubMed Web of Science ®Google Scholar
• GUPTA A, CHANDRASEKHAR S, PAL R, AHLAWAT S, SINGH O: High expression of human chorionic gonadotrophin beta-subunit using a synthetic vaccinia virus promoter. Endocrinol (2001) 26:281–287
   Web of Science ®Google Scholar
• CHIESA MD, MARTENSEN PM, SIMMONS C et al.: Refocusing of B-cell responses following a single amino acid substitution in an antigen. Immunology (2001) 103:172–178.
   PubMed Web of Science ®Google Scholar
• •An example of how careful modification of a peptide antigen can redirect the immune response to achieve an improvement in target specificity.
   Google Scholar
• SHAH S, RAGHUPATHY R, SINGH O, TALWAR GP, SODHI A et al.: Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine. Vaccine (1999) 17:3116–3123.
   PubMed Web of Science ®Google Scholar
• MOUD GAL NR, MURTHY GS, PRASANNA KUMAR KM et al.: Responsiveness of human male volunteers to immunization with ovine follicle stimulating hormone vaccine: results of a pilot study. Hum. Reprod. (1997) 12:457–463.
   Google Scholar
• ZENG W, GHOSH S, LAU YF, BROWN LE, JACKSON DC: Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.' Immunol. (2002) 169:4905–4912.
   Web of Science ®Google Scholar
• DELVES PJ, LUND T, ROITT IM: Antifertility vaccines. Trends Immunol (2002) 23:213–219.
   PubMed Web of Science ®Google Scholar
• BRANDTZAEG P: The oral immune system under normal and pathological conditions. Pathol Res. Pract. (1985) 179:619–621.
   PubMed Web of Science ®Google Scholar
• CONLEY ME, DELACROIX DL: Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defence? Ann. Intern. Med. (1987) 106:892–899.
   Web of Science ®Google Scholar
• MESTECKY J, LUE C, RUSSELL MW et al.: Selective transport of IgA. Cellular and molecular aspects. Gastroenterol Clin. North Am. (1991) 20:441–471
   PubMed Web of Science ®Google Scholar
• KUTTEH WH, MESTECKY J: Theconcept of mucosal immunology. In: Reproductive Immunology Bronson RA, Alexander NJ, Anderson DJ, Branch DW, Kutteh WH (Eds), Blackwell Science Ltd, Oxford (1996):28–51.
   Google Scholar
• ••A thorough review of mucosal immunity.
   Google Scholar
• EGGERT-KRUSE W,BOCKEM-HELLWIG S, DOLL A, ROHR G, TILGEN W, RUNNEBAUM B: Antisperm antibodies in cervical mucus in an unselected subfertile population. Hum. Reprod. (1993) 8:1025–1031.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL KL, GALLICHAN WS: Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract. Semin. Immunol (1997) 9:303–314.
   PubMedGoogle Scholar
• RUSSELL MW, MOLDOVEANU Z, WHITE PL, SIBERT GJ, MESTECKY J, MICHALEK SM: Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect. Immun. (1996) 64:1272–1283.
   PubMed Web of Science ®Google Scholar
• •Paper demonstrating the feasibility of inducing generalised IgA antibody responses in the mucosal immune system through the intranasal administration of antigen.
   Google Scholar
• RASK C, FREDRIKSSON M, LINDBLAD M, CZERKINSKY C, HOLMGREN J: Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/ or of co-administration with free toxin as adjuvant. APMIS (2000) 108:178–186.
   PubMed Web of Science ®Google Scholar
• FRANKLIN RD, KUTTEH WH: Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. I Reprod. Immunol (1999) 42:93–106.
   PubMed Web of Science ®Google Scholar
• MCGHEE JR, MESTECKY J,ELSON CO, KIYONO H: Regulation of IgA synthesis and immune response by T cells and interleukins. Clin. Immunol. (1989) 9:175–199.
   Web of Science ®Google Scholar
• PRABHALA RH, WIRA CR: Cytokine regulation of the mucosal immune system: in vivo stimulation by interferon-gamma of secretory component and immunoglobulin A in uterine secretions and proliferation of lymphocytes from spleen. Endocrinology (1991) 129:2915-2923.aa. PRABHALA RH, WIRA CR: Influence of estrous cycle and estradiol on mitogenic responses of splenic T- and B-lymphocytes. Adv. Exp. Med. Biol. (1995) 371A:379–381.
   Google Scholar
• KUTTEH WH, MOLDOVEANU Z, MESTECKY J et al.: Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res. Hum. Retroviruses (1998) 14\(Suppl. 1):551–555.
   Google Scholar
• EDWARDS RP, KUYKENDALL K, CROWLEY-NOWICK P,PARTRIDGE EE, SHINGLETON HM, MESTECKY J: T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion. Cancer (1995) 76:1411–1415.
   Google Scholar
• GLENN GM, SCHARTON-KERSTEN T, VASSELL R, MALLETT CP, HALE TL, ALVING CR: Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. Immunol (1998) 161:3211–3214.
   Web of Science ®Google Scholar
• GLENN GM, SCHARTON-KERSTEN T, VASSELL R, MATYAS GR, ALVING CR: Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect. Immun, (1999) 67:1100–1106.
   PubMed Web of Science ®Google Scholar
• GOCKEL CM, BAO S, BEAGLEY KW: Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. Ma Immunol. (2000) 37:537–544.
   PubMed Web of Science ®Google Scholar
• GLENN GM, TAYLOR DN, LI X, FRANKEL S, MONTEMARANO A, ALVING CR: Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat. Med. (2000) 6:1403–1406.
   PubMed Web of Science ®Google Scholar
• ULANOVA M, TARKOWSKI A, HAHN-ZORIC M, HANSON LA: The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism. Infect. Immun. (2001) 69:1151–1159.
   PubMed Web of Science ®Google Scholar
• GREER CE, PETRACCA R, BUONAMASSA DT et al.: The comparison of the effect ofLTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus Type 6b (HPV-6b) virus-like particles. Vaccine (2000) 19:1008–1012.
   PubMed Web of Science ®Google Scholar
• EVANS TG, MCELRATH MJ,MATTHEWS T et al.: QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans. Vaccine (2001) 19:2080–2091.
   Google Scholar
• KIM SK, RAGUPATHI G, CAPPELLO S, KAGAN E, LIVINGSTON PO: Effect of immunological adjuvant combinations on the antibody and T- cell response to vaccination with MUC1-KLH and GD3-KLH conjugates. Vaccine (2000) 19:530–537.
   PubMed Web of Science ®Google Scholar
• FREIDAG BL, MELTON GB,COLLINS F et al.: CpGoligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M tuberculosis. Infect. Immun. (2000) 68:2948–2953.
   Google Scholar
• BUCHANAN RM, BRILES DE, ARULANANDAM BP,WESTERINK MA, RAEDER RH, METZGER DW: IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines. Vaccine (2001) 19: 2020-2028.
   Google Scholar
• HANCOCK GE, HEERS KM, SMITH JD: QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusionprotein of respiratory syncytial virus. Viral Inonunol. (2000) 13:503–509.
   PubMed Web of Science ®Google Scholar
• SHEDLOCK DJ, WEINER DB: DNA vaccination: antigen presentation and the induction of immunity. I Leukoc. (2000) 68:793–806.
   PubMed Web of Science ®Google Scholar
• •Review of DNA vaccination strategy.
   Google Scholar
• DONNELLY JJ, ULMER JB:DNA vaccines for viral diseases. Braz. Med. Biol. Res. (1999) 32:215–222.
   Web of Science ®Google Scholar
• RAMSHAW IA, RAMSAY AJ: The prime-boost strategy: exciting prospects for improved vaccination. brununol. Today (2000) 21:163–165.
   PubMed Web of Science ®Google Scholar
• DELIYANNIS G, BOYLE JS, BRADY JL, BROWN LE, LEW AM: A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc. Natl. Acad. Sci. USA (2000) 97:6676–6680.
   PubMed Web of Science ®Google Scholar
• HUANG TH, WU PY, LEE CN et a/.: Enhanced antitumor immunity by fusion of CTLA-4 to a self tumor antigen. Blood (2000) 96:3663–3670.
   Google Scholar
• LEW AM, BRADY BJ, BOYLE BJ: Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions. Vaccine (2000) 18:1681–1685.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ F, ZHANG J,WHITTON JL: DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. Virol. (1997) 71:8497–8503.
   Web of Science ®Google Scholar
• CHEN Y, LIU Z, YANG Y, CHEN YZ, PENG JP: Infertility in mice induced by the rhesus monkey chorionic gonadotropin beta-subunit glycoprotein (rmCGbeta) using DNA immunization. Mol Cell Biochern. (2002) 231:89–96.
   PubMed Web of Science ®Google Scholar
• XIANG RL, ZHOU F, YANG Y, PENG JP: Construction of the plasmid pCMV4-rZPC' DNA vaccine and analysis of its contraceptive potential. Biol. Reprod. (2003) 68:1518–24.
   PubMed Web of Science ®Google Scholar
• COONROD SA, WRIGHT PW, HERR JC: Oolemmal proteomics. Reprod. brununol. (2002) 53:55–65.
   Google Scholar
• KASS E, PANICALI DL, MAZZARA G, SCHLOM J, GREINER JW: Granulocyte/ macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant. Cancer Res. (2001) 61:206–214.
   PubMed Web of Science ®Google Scholar
• JACKSON RJ, RAMSAY AJ, CHRISTENSEN CD, BEATON S, HALL DF, RAMSHAW IA: Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. Vim/. (2001) 75:1205–1210.
   Web of Science ®Google Scholar
• http://esa.un.org/unpp/UNITED NATIONS POPULATION DIVISION: World population prospects: the 2002 revision. Population database (2002).
   Google Scholar